COST STUDY OF ASSISTED REPRODUCTIVE TECHNOLOGIES IN UKRAINE
Author(s)
Horbachevska K, Zalis'ka O, Maksymovych N
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine
Presentation Documents
OBJECTIVES: At the most European countries the cost for assisted reproductive technology (ART) are compensated from state and insurance funds. At the first in Ukraine state funding of ART was launched on the Orders of MoH №579 from 24.11.2004. However, most patients have to pay own out-of-pocket costs for ART. METHODS: We evaluated the general cost of short and long stimulation protocols for ART of new Order of MOH Ukraine №771 from 23.12.2008 "On Approval of Instruction on the use of assisted reproductive technologies". Cost analysis for short and long protocols, based on the comparison of costs during 2014 and 2015 in Ukraine. RESULTS: We used the prices from database Morion (Kiyv) on 01.04.2015 and analysed the cost for short protocol. The stimulation of superovulation with Puregon was 18000 UAH (1Euro=24.7 UAH) or with Elonva was 13 000 UAH. Also cost on other medicines were included. In average, a general cost per 1 cycle was 16 600 UAH. Were analyzed the cost of ART long protocol. We included the cost with Diferelin depot that was 2800 UAH. The cost of stimulation of superovulation with Puregon was 18000 UAH. In average, a general cost per 1 cycle was 24 000 UAH. We compared the cost data on ART during 2014-2015. The average salary was 3998 UAH on 01.04.2015 in Ukraine. CONCLUSIONS: Comparing data 2014 and 2015 were founded, that the cost of short protocol increased by 27% and by 41% the long one. It was established that the cost of ART are high. Revealed that the cost of ART is 4-6 times higher than the average salary, therefore the availability of ART for families is low. It is necessary to determine the budget financing for ART to improve access to ART in Ukraine.
Conference/Value in Health Info
2015-11, ISPOR Europe 2015, Milan, Italy
Value in Health, Vol. 18, No. 7 (November 2015)
Code
PIH14
Topic
Economic Evaluation
Topic Subcategory
Cost/Cost of Illness/Resource Use Studies
Disease
Reproductive and Sexual Health